.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Argus Health
Dow
Healthtrust
Citi
Mallinckrodt
Cipla
McKinsey
Queensland Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Expectorants

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen IncACETYLCYSTEINEacetylcysteineSOLUTION;INHALATION, ORAL204674-001Feb 11, 2014ANRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Fresenius Kabi UsaACETYLCYSTEINEacetylcysteineINJECTABLE;INTRAVENOUS200644-001Nov 7, 2012APRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
ApotheconMUCOMYSTacetylcysteineSOLUTION;INHALATION, ORAL013601-001Approved Prior to Jan 1, 1982DISCNYesNo➤ Sign Up➤ Sign Up➤ Sign Up
LuitpoldACETYLCYSTEINEacetylcysteineSOLUTION;INHALATION, ORAL072547-001Jul 28, 1995ANRXNoYes➤ Sign Up➤ Sign Up➤ Sign Up
Actavis Labs FlGUAIFENESINguaifenesinTABLET, EXTENDED RELEASE;ORAL091009-002Sep 3, 2015OTCNoNo➤ Sign Up➤ Sign Up➤ Sign Up
ApotheconMUCOMYSTacetylcysteineSOLUTION;INHALATION, ORAL013601-002Approved Prior to Jan 1, 1982DISCNYesNo➤ Sign Up➤ Sign Up➤ Sign Up
Arbor Pharms LlcCETYLEVacetylcysteineTABLET, EFFERVESCENT;ORAL207916-002Jan 29, 2016RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
Perrigo R And DGUAIFENESINguaifenesinTABLET, EXTENDED RELEASE;ORAL078912-001Nov 23, 2011OTCNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Guardian PharmsGUAIFENESINguaifenesinTABLET, EXTENDED RELEASE;ORAL209215-001Sep 6, 2017OTCNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Arbor Pharms LlcCETYLEVacetylcysteineTABLET, EFFERVESCENT;ORAL207916-001Jan 29, 2016RXYesNo➤ Sign Up➤ Sign UpY➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Covington
Cerilliant
QuintilesIMS
Dow
UBS
Johnson and Johnson
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot